A ROS rheostat for cell fate regulation

Trends in Cell Biology

Volumn 23, Issue 3, 2013, Pages 129-134

  Maryanovich, Maria ^a   Gross, Atan ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

ATM; BID; Cell cycle regulation; Hematopoietic lineage; Mitochondria; Reactive oxygen species; Stem cell biology

Indexed keywords

BIM PROTEIN; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOCHONDRIAL PROTEIN; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN MCL 1; REACTIVE OXYGEN METABOLITE;

BIOACCUMULATION; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CHROMATIN STRUCTURE; DNA METHYLATION; DNA MODIFICATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; INHIBITION KINETICS; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MITOCHONDRIA; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84874260968     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2012.09.007     Document Type: Review

References (61)

1. Rehman J. Empowering self-renewal and differentiation: the role of mitochondria in stem cells. J. Mol. Med. 2010, 88:981-986.
2. Suda T., et al. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 2011, 9:298-310.
3. Sarsour E.H., et al. Redox control of the cell cycle in health and disease. Antioxid. Redox Signal. 2009, 11:2985-3011.
4. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
5. Orford K.W., Scadden D.T. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat. Rev. Genet. 2008, 9:115-128.
6. Doyle K., Fitzpatrick F.A. Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J. Biol. Chem. 2010, 285:17417-17424.
7. Guo Z., et al. ATM activation by oxidative stress. Science 2010, 330:517-521.
8. Ditch S., Paull T.T. The ATM protein kinase and cellular redox signaling: beyond the DNA damage response. Trends Biochem. Sci. 2012, 37:15-22.
9. Salih D.A.M., Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr. Opin. Cell Biol. 2008, 20:126-136.
10. Fau H.P., Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 1993, 53:4469-4473.
11. Rainwater R., et al. Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol. 1995, 15:3892-3903.
12. Sablina A.A., et al. The antioxidant function of the p53 tumor suppressor. Nat. Med. 2005, 11:1306-1313.
13. Asai T., et al. The p53 tumor suppressor protein regulates hematopoietic stem cell fate. J. Cell. Physiol. 2011, 226:2215-2221.
14. Liu Y., et al. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009, 4:37-48.
15. Janssen-Heininger Y.M.W., et al. Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb. Free Radic. Biol. Med. 2000, 28:1317-1327.
16. Lonergan T., et al. Differentiation-related changes in mitochondrial properties as indicators of stem cell competence. J. Cell. Physiol. 2006, 208:149-153.
17. Al-Mehdi A-B., et al. Perinuclear mitochondrial clustering creates an oxidant-rich nuclear domain required for hypoxia-induced transcription. Sci. Signal. 2012, 5:ra47.
18. Valentin-Vega Y.A., et al. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 2012, 119:1490-1500.
19. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116:205-219.
20. Willis S.N., Adams J.M. Life in the balance: how BH3-only proteins induce apoptosis. Curr. Opin. Cell Biol. 2005, 17:617-625.
21. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
22. Opferman J.T., et al. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005, 307:1101-1104.
23. Perciavalle R.M., et al. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. Nat. Cell Biol. 2012, 14:575-583.
24. Chen Y-B., et al. Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J. Cell Biol. 2011, 195:263-276.
25. Alavian K.N., et al. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nat. Cell Biol. 2011, 13:1224-1233.
26. Wiese C., et al. Gene conversion is strongly induced in human cells by double-strand breaks and is modulated by the expression of BCL-x(L). Cancer Res. 2002, 62:1279-1283.
27. Janumyan Y.M., et al. Bcl-xL/Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry. EMBO J. 2003, 22:5459-5470.
28. Motoyama N., et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995, 267:1506-1510.
29. Zinkel S.S., et al. Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes Dev. 2003, 17:229-239.
30. Liu Y., et al. Bid protects the mouse hematopoietic system following hydroxyurea-induced replicative stress. Cell Death Differ. 2012, 19:1602-1612.
31. Maryanovich M., et al. The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells. Nat. Cell Biol. 2012, 14:535-541.
32. Bouillet P., et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999, 286:1735-1738.
33. Kuribara R., et al. Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors. Mol. Cell. Biol. 2004, 24:6172-6183.
34. Jeffers J.R., et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 2003, 4:321-328.
35. Villunger A., et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003, 302:1036-1038.
36. Yu H., et al. Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose γ-irradiation. Blood 2010, 115:3472-3480.
37. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 2001, 15:2922-2933.
38. Desagher S., et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 1999, 144:891-901.
39. Sarig R., et al. BID-D59A is a potent inducer of apoptosis in primary embryonic fibroblasts. J. Biol. Chem. 2003, 278:10707-10715.
40. Tafani M., et al. Cytochrome c release upon Fas receptor activation depends on translocation of full-length Bid and the Induction of the mitochondrial permeability transition. J. Biol. Chem. 2002, 277:10073-10082.
41. Valentijn A.J., Gilmore A.P. Translocation of full-length Bid to mitochondria during anoikis. J. Biol. Chem. 2004, 279:32848-32857.
42. Kamer I., et al. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 2005, 122:593-603.
43. Oberkovitz G., et al. Nucleocytoplasmic shuttling of BID is involved in regulating its activities in the DNA-damage response. Cell Death Differ. 2007, 14:1628-1634.
44. Zinkel S.S., et al. A role for proapoptotic BID in the DNA-damage response. Cell 2005, 122:579-591.
45. Jang Y.Y., Sharkis S.J. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 2007, 110:3056-3063.
46. Juntilla M.M., et al. AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. Blood 2010, 115:4030-4038.
47. Parmar K., et al. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5431-5436.
48. Tesio M., et al. Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signaling. Blood 2011, 117:419-428.
49. Ito K., et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431:997-1002.
50. Ito K., et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 2006, 12:446-451.
51. Barlow C. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:871-876.
52. Yang Y., et al. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-κB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol. Cell. Biol. 2011, 31:2774-2786.
53. Hinz M., et al. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation. Mol. Cell 2010, 40:63-74.
54. Liu Y., et al. Proapoptotic Bid mediates the Atr-directed DNA damage response to replicative stress. Cell Death Differ. 2010, 18:841-852.
55. Edlich F., et al. Bcl-xL retrotranslocates bax from the mitochondria into the cytosol. Cell 2011, 145:104-116.
56. Lavin M.F., Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 1997, 15:177-202.
57. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 2008, 9:759-769.
58. Zaltsman Y., et al. MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria. Nat. Cell Biol. 2010, 12:553-562.
59. Willer C.J., et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 2009, 41:25-34.
60. Schneider J.G., et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab. 2006, 4:377-389.
61. Yang D-Q., Kastan M.B. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat. Cell Biol. 2000, 2:893-898.